SUNTREEclaims registerCheck my label

Register / Fatty acid

Omega-3 (DHA and EPA)

4 authorised claims · NRV 250 mg DHA + EPA

authorised

What the regulation allows

  • “Omega-3 DHA contributes to the maintenance of normal brain function”
  • “Omega-3 DHA contributes to the maintenance of normal vision”
  • “Omega-3 EPA and DHA contribute to the normal function of the heart”
  • “Omega-3 DHA and EPA contribute to the maintenance of normal blood triglyceride levels”

Dose condition

heart: at least a source of EPA+DHA (15% of the 250 mg NRV, i.e. 37.5 mg per daily portion), with a statement that the benefit is obtained at 250 mg/day. brain and vision: at least 40 mg of DHA per 100 g AND per 100 kcal, with a statement that the benefit is obtained at 250 mg DHA/day

Reg. 432/2012, Annex. 'DHA contributes to maintenance of normal brain function' and '…normal vision' may be used only for food containing at least 40 mg of DHA per 100 g and per 100 kcal. That is a density test, not a per-portion test: at roughly 330 kcal per 100 g a gummy needs about 3 mg of DHA per piece to clear the 100 kcal limb, but the pack must still tell the consumer that 250 mg/day is what the evidence used.

Wording that fails

PhraseWhy it fails
“Omega-3 prevents heart attack”Reads as a disease claim, which needs an Article 14 authorisation.
“Omega-3 improves memory”Claims an effect beyond maintenance of normal function.
“Omega-3 reduces inflammation”Not among the authorised wordings for this substance.

In a gummy

3 mg of DHA is easy; 250 mg is not. 250 mg of oil in a 2.5 g piece is 10% of the piece weight and it softens the matrix, then oxidises into a fishy note. So a gummy can carry the brain claim on a dose that does nothing, which is legal and commercially awkward. Emulsified or powdered algal DHA is the usual route at 20–50 mg.

Marketing phrases that touch this substance

PhraseVerdictAuthorised alternative
Supports heart healthConditionalEPA and DHA contribute to the normal function of the heart